Gould Gregory A
SEC-identified person · CIK 1252905 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Aclarion, Inc. ACON | Chief Financial Officer | filed 2025–2026 |
| Charlotte's Web Holdings, Inc. CWBHF) | Chief Financial Officer | filed 2022–2022 |
| Newage, Inc. NBEV | Chief Financial Officer | filed 2018–2021 |
| Cytodyn Inc. cydy | Director | filed 2006–2019 |
| Rosewind Corp RSWN | Chief Financial Officer | filed 2015–2017 |
| Ampio Pharmaceuticals, Inc. AMPE | Chief Financial Officer | filed 2014–2016 |
| Seracare Life Sciences INC srls | Interim CEO, CFO, Treas. & Sec | filed 2006–2012 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.